These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16537848)

  • 1. Treatment with AM3 restores defective T-cell function in COPD patients.
    Reyes E; Prieto A; de la Hera A; de Lucas P; Alvarez-Sala R; Alvarez-Sala JL; Alvarez-Mon M
    Chest; 2006 Mar; 129(3):527-35. PubMed ID: 16537848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD.
    Alvarez-Mon M; Miravitlles M; Morera J; Callol L; Alvarez-Sala JL
    Chest; 2005 Apr; 127(4):1212-8. PubMed ID: 15821197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferón).
    Prieto A; Reyes E; Bernstein ED; Martinez B; Monserrat J; Izquierdo JL; Callol L; de LUCAS P; Alvarez-Sala R; Alvarez-Sala JL; Villarrubia VG; Alvarez-Mon M
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1578-83. PubMed ID: 11401877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis.
    Albillos A; Nieto M; Ubeda M; Muñoz L; Fraile B; Reyes E; Lledó L; Blanco I; Pastor O; Salas C; Lario M; Monserrat J; Bataller R; Alvarez-Mon M
    Gut; 2010 Jul; 59(7):943-52. PubMed ID: 20442198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of AM3 on health-related quality of life in patients with chronic obstructive pulmonary disease belonging to risk groups].
    Miravitlles M; Murio C; Morera J; Callol L; Alvarez-Sala JL; Alvarez-Mon M
    Med Clin (Barc); 2008 May; 130(18):688-92. PubMed ID: 18501139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic response of chronic active hepatitis B (CAHB) to a new immunomodulator: AM3. Immunohematological effects.
    Villarrubia VG; Valladolid JM; Elorza FL; Sada G; Vilchez JG; Jimenez M; Herrerias JM
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):141-64. PubMed ID: 1597653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD.
    Shirai T; Suda T; Inui N; Chida K
    Allergol Int; 2010 Mar; 59(1):75-82. PubMed ID: 20035145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
    Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects.
    Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    Clin Exp Immunol; 2007 Oct; 150(1):22-9. PubMed ID: 17614970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD.
    Paats MS; Bergen IM; Hoogsteden HC; van der Eerden MM; Hendriks RW
    Eur Respir J; 2012 Aug; 40(2):330-7. PubMed ID: 22183488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of immunomodulator AM3 on the exacerbations in patients with chronic bronchitis: a systematic review of controlled trials].
    Reyes Martín E; Fernández Almendros C; Alvarez-Sala JL; Alvarez-Mon M
    Rev Clin Esp; 2004 Sep; 204(9):466-71. PubMed ID: 15388020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion.
    Folli C; Chiappori A; Pellegrini M; Garelli V; Riccio AM; De Ferrari L; Braido F; Canonica GW
    Pulm Pharmacol Ther; 2012 Oct; 25(5):371-6. PubMed ID: 22766315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3.
    Villarrubia VG; Moreno Koch MC; Calvo C; González S; Alvarez-Mon M
    Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):53-74. PubMed ID: 9049659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and cytokine immunoregulation in patients with chronic obstructive pulmonary disease and bronchial asthma.
    Stankiewicz W; Dabrowski MP; Chcialowski A; Plusa T
    Mediators Inflamm; 2002 Oct; 11(5):307-12. PubMed ID: 12467523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis.
    Szyllo K; Tchorzewski H; Banasik M; Glowacka E; Lewkowicz P; Kamer-Bartosinska A
    Mediators Inflamm; 2003 Jun; 12(3):131-8. PubMed ID: 12857596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
    Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against muscle damage in competitive sports players: the effect of the immunomodulator AM3.
    Córdova A; Martin JF; Reyes E; Alvarez-Mon M
    J Sports Sci; 2004 Sep; 22(9):827-33. PubMed ID: 15513276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral Tc17 and Tc17/Interferon-γ Cells are Increased and Associated with Lung Function in Patients with Chronic Obstructive Pulmonary Disease.
    Xu WH; Hu XL; Liu XF; Bai P; Sun YC
    Chin Med J (Engl); 2016 Apr; 129(8):909-16. PubMed ID: 27064034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.